Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

KAI1/CD82, a tumor metastasis suppressor.

Wei M Liu1, Xin A Zhang

  • 1Vascular Biology Center and Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Cancer Letters
|November 2, 2005
PubMed
Summary

Tetraspanin KAI1/CD82 acts as a broad tumor metastasis suppressor by inhibiting cancer cell movement and invasion. Its loss in cancers is linked to epigenetic changes involving key transcription factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer.

Molecular cancer·2026
Same author

Interaction between CD82 and integrin αVβ3 selectively regulates collective movement of tumor cells via endolysosomal trafficking.

Cellular and molecular life sciences : CMLS·2026
Same author

Publisher Correction: Tetraspanin-enriched membrane domains regulate vascular leakage by altering membrane cholesterol accessibility to balance antagonistic GTPases.

Nature cardiovascular research·2025
Same author

Tetraspanin-enriched membrane domains regulate vascular leakage by altering membrane cholesterol accessibility to balance antagonistic GTPases.

Nature cardiovascular research·2025
Same author

Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages.

GeroScience·2024
Same author

CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation.

Circulation research·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tetraspanin KAI1/CD82 is recognized as a broad-spectrum suppressor of tumor metastasis.
  • KAI1/CD82 primarily functions by inhibiting cancer cell motility and invasiveness.
  • Within tetraspanin-enriched microdomains, KAI1/CD82 interacts with proteins crucial for cell migration.

Purpose of the Study:

  • To elucidate the mechanism by which KAI1/CD82 suppresses tumor metastasis.
  • To understand the association of KAI1/CD82 with motility-related proteins.
  • To investigate the epigenetic regulation of KAI1/CD82 expression in invasive cancers.

Main Methods:

  • Analysis of KAI1/CD82 protein interactions within tetraspanin-enriched microdomains.
  • Investigating the functional impact of KAI1/CD82 on cancer cell motility and invasiveness.
  • Examining the epigenetic mechanisms, including transcription factor involvement (NF-kappaB, p53, beta-catenin), underlying KAI1/CD82 expression loss.

Main Results:

  • KAI1/CD82 associates with cell adhesion molecules, growth factor receptors, and signaling molecules involved in cell migration.
  • KAI1/CD82 appears to down-regulate the functions of these motility-related proteins, thereby inhibiting cell migration.
  • Loss of KAI1/CD82 expression in invasive and metastatic cancers is associated with complex epigenetic mechanisms.

Conclusions:

  • KAI1/CD82 is a critical suppressor of tumor metastasis, acting by inhibiting cancer cell motility and invasiveness.
  • Epigenetic alterations, potentially involving transcription factors like NF-kappaB, p53, and beta-catenin, contribute to KAI1/CD82 expression loss in aggressive cancers.

Related Experiment Videos